Mourad Ishak – General Manager MEA Region, Farmak
Mourad Ishak began heading up Farmak’s MEA region as general manager in 2021, after almost two decades in the industry. He explains the Ukranian complex generics maker’s decision to set…
Address: 63 Frunze St., Kyiv, Ukraine
Tel: +38 044496-89-63
Web: http://farmak.ua/en/
The Open Joint Stock Company Farmak is one of the oldest pharmaceutical companies in Ukraine, manufacturing finished medicines and pharmaceutical substances. The company was established in 1991 on the basis of Kiev’s M. V. Lomonosov Chemical-Pharmaceutical Plant, which began producing synthetic medicines in 1925. Over the 80 years of its existence the company has become one of the leading manufacturers in the local pharmaceutical industry.
endocrinology, ophthalmology, otolaringology, X-ray contrast media, ophthalmology, otolaringology, X-ray contrast media
Mourad Ishak began heading up Farmak’s MEA region as general manager in 2021, after almost two decades in the industry. He explains the Ukranian complex generics maker’s decision to set…
In 1996, Jiří Žák, chairman & current CEO of FARMAK, took over the state-owned producer of vitamins FARMAKON where he previously worked for 30 years and turned it into a…
Filya Zhebrovska, chairman of the supervisory board of Farmak and the company’s general director between 1995 and 2017, provides insights into the strategy she has followed to establish Farmak as…
Petro Bagriy, president of the Association of Drug Manufacturers of Ukraine (AMMU), which gathers seven of the leading Ukrainian pharmaceutical companies, provides insights into the internal workings of the association…
Robert Chagalian, country manager of Siemens Healthineers Ukraine, provides a fascinating insight into the 165-year long presence of Siemens on the Ukrainian market, whilst highlighting the strong commitment of the…
Aleksandr Iavorskyi, founder and president of Biocon, Ukraine’s leading third-party logistics (3PL) company in the pharmaceutical and healthcare areas, provides insights into Biocon’s impressive development and unique partnership approach as…
Victoria Bandyk, chief operating officer of the Bioscience Group, provides insights into the unique added value and the international development of this comprehensive group of companies, which aims to support…
Roman Gladkyi, general manager of Ferring Ukraine, describes the current opportunities and areas for improvement he identifies within Ukraine’s pharmaceutical market and the country’s evolving heath system, with a special…
Evgeniy Gaydukov, Country Director of AstraZeneca Ukraine, provides insights into the remarkable growth that the science-led, innovative company has been experiencing in Ukraine despite the unstable economic situation in the…
Anatoliy Novyk, founder and president of SMC Ecopharm, the only Ukrainian pharmaceutical company to be exclusively focused on its own original drug development, provides insights into Ecopharm’s promising expansion strategy,…
Filya Zhebrovska, chairman of the supervisory board of Farmak and the company’s general director between 1995 and 2017, provides insights into the strategy she has followed to establish Farmak as…
Taras Velgosh, Adamed’s country manager in Ukraine, provides insights into the great results accomplished by the Ukrainian affiliate of this leading Polish pharmaceutical company despite the deep crisis that has…
Liana Maksyoutova, country manager of Polpharma Ukraine, provides insights into the impressive transformation of the Ukrainian affiliate that she has fostered since inheriting its reins in 2012 and how she…
Anatoliy Reder, founder and general director of InterChem, provides insights into the heightened international ambitions of this leading, science-based Ukrainian pharmaceutical company, which plans to leverage its unique R&D and…
Natalia Zago, managing director of Takeda Ukraine, one of the leading international companies operating in the country, provides insights into her main priorities to drive the growth of the company…
See our Cookie Privacy Policy Here
